Skip to content
The Policy VaultThe Policy Vault

Jakafi (ruxolitinib) — Medica

Graft-Versus-Host Disease, Acute

Initial criteria

  • age ≥ 12 years
  • patient has tried one systemic corticosteroid

Approval duration

1 year